- Home
- CIGL vs PDSB Comparison
CIGL vs PDSB Comparison
Compare CIGL & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIGL
- PDSB
- Stock Information
- Founded
- CIGL 1997
- PDSB 2005
- Country
- CIGL Singapore
- PDSB United States
- Employees
- CIGL N/A
- PDSB N/A
- Industry
- CIGL Diversified Commercial Services
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- CIGL Consumer Discretionary
- PDSB Health Care
- Exchange
- CIGL Nasdaq
- PDSB Nasdaq
- Market Cap
- CIGL 46.7M
- PDSB 54.5M
- IPO Year
- CIGL 2025
- PDSB N/A
- Fundamental
- Price
- CIGL $3.46
- PDSB $1.16
- Analyst Decision
- CIGL
- PDSB Strong Buy
- Analyst Count
- CIGL 0
- PDSB 2
- Target Price
- CIGL N/A
- PDSB $10.00
- AVG Volume (30 Days)
- CIGL 7.9M
- PDSB 555.4K
- Earning Date
- CIGL 01-01-0001
- PDSB 11-13-2025
- Dividend Yield
- CIGL N/A
- PDSB N/A
- EPS Growth
- CIGL N/A
- PDSB N/A
- EPS
- CIGL N/A
- PDSB N/A
- Revenue
- CIGL $10,490,668.00
- PDSB N/A
- Revenue This Year
- CIGL N/A
- PDSB N/A
- Revenue Next Year
- CIGL N/A
- PDSB N/A
- P/E Ratio
- CIGL N/A
- PDSB N/A
- Revenue Growth
- CIGL N/A
- PDSB N/A
- 52 Week Low
- CIGL $1.40
- PDSB $0.85
- 52 Week High
- CIGL $31.06
- PDSB $4.29
- Technical
- Relative Strength Index (RSI)
- CIGL N/A
- PDSB 44.74
- Support Level
- CIGL N/A
- PDSB $1.13
- Resistance Level
- CIGL N/A
- PDSB $1.26
- Average True Range (ATR)
- CIGL 0.00
- PDSB 0.09
- MACD
- CIGL 0.00
- PDSB -0.01
- Stochastic Oscillator
- CIGL 0.00
- PDSB 8.82
About CIGL Concorde International Group Ltd Class A Ordinary Shares
Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.